G4MWY1 AF NFT

Type 2 glycosyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeie7wts4lm76raeduzqwqbjbl7bawuuqx4qinlnq6g3uwsgxedgb4q/metadata.json
IPFS of structure file: 
bafybeia2obartjdmiuknbvtvptfxot3q7dj24oug5lx3m67qbgkkjlnuqq/AF-G4MWY1-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x7FC89EC214E88EEb38fAa127e1E19d1b331AC902
First NFT owner address (bech32): 
genesis10lyfass5az8wkw865yn7rcvarve34jgzt72gd4
Current NFT ID #160845 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
160845
Accession (UniProt):
G4MWY1
Name::
Type 2 glycosyltransferase
Experimental Method:
Predicted structure
Sequence source:
MAGNAPORTHE ORYZAE (STRAIN 70-15 / ATCC MYA-4617 / FGSC 8958)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT G4MWY1 research and analysis (ICN3D with VR)

FASTA sequences

>sp|G4MWY1|GT2_MAGO7 Type 2 glycosyltransferase OS=Magnaporthe oryzae (strain 70-15 / ATCC MYA-4617 / FGSC 8958) OX=242507 GN=GT2 PE=1 SV=1 MATPLQIMPLPVWPITFLEDAVVYLSALFTPWFTAFCVLWLHRYVRLIVHCYSHWTYKSKPIPSKPSYTSDDVTVVIPTIHDNFDELRPSLESILATKPHELIMVTTADKFEDLQRVAKTLSSPNIRIFCTQYANKRIQVCEALPKITTRITIMADDDVTWPSTMMPWILAPFEDPKIGGVGTCQRVKRVREGGLGLRIWNWLGAAYIERRNFEISATHNMDGGTSCMSGRTGAYRSEILRDYEFLEGFMKEEWWGKILKADDDNFVSRWLVSHKWKTWIQYEQECELETTLEDNIKFLYQCSRWARSNWRSNWTSLVKERHVWKQQWWCTYALHIATFTSLAFVFDFLILAALWWGTEGWEPVNRNRAIYAQLAFLAFSKVVKLVGLFRRHPADIMFLPVSIIFGYFHGLIKIYAGLTLNMTSWGSRTDGDTDDAHRLAPGPVRCSSLNTPRSEHKLPHYMQERDEIVNEKQQMREEEWEHL